BW

Keysight Enables DEKRA to Validate Mobile Phone E112 Caller Location in Compliance with New Regulation

Collaboration supports emergency services across the European Union SANTA ROSA, Calif.--(BUSINESS WIRE)--$KEYS #5G--Keysight Technologies, Inc. (NYSE: KEYS), a leading technology company that delivers advanced design and validation solutions to help accelerate innovation to connect and secure the world, announced a collaboration with DEKRA, a leading global test house network, to…
Leer más...

Final Deadline Alert – Bronstein, Gewirtz & Grossman, LLC Notifies AbbVie, Inc. (ABBV) Investors of Class Action and Last Few Hours to Actively Participate

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against AbbVie, Inc. ("AbbVie" or the “Company) (NYSE: ABBV) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired AbbVie securities between April 30, 2021,…
Leer más...

Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting

-- Interim results of tisotumab vedotin plus pembrolizumab from Phase 1b/2 innovaTV 205 trial, showing 41% objective response rate in first-line patients with recurrent or metastatic cervical cancer (r/mCC), to be presented in an oral session -- -- Additional poster presentations to include debut of web-based tool for identifying geographical…
Leer más...

Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting

-- Interim results of tisotumab vedotin plus pembrolizumab from Phase 1b/2 innovaTV 205 trial, showing 41% objective response rate in first-line patients with recurrent or metastatic cervical cancer (r/mCC), to be presented in an oral session -- -- Additional poster presentations to include debut of web-based tool for identifying geographical…
Leer más...

EA to Host Apex Legends™ Global Series Year 2 Championship at PNC Arena in Raleigh, North Carolina, on July 7-10

World’s Best Apex Legends Squads to Compete in First ALGS Championship Event in Front of Live Audience ALGS Championship Arrives as the Split 2 Playoffs Final Shatters Previous Franchise Records with AMA of 539,000 Across Channels REDWOOD CITY, Calif.--(BUSINESS WIRE)--Electronic Arts (NASDAQ: EA), a worldwide leader in interactive entertainment, today…
Leer más...

Messagepoint Named a Leader in IDC MarketScape: Worldwide Cloud Customer Communications Management 2022 Vendor Assessment

TORONTO--(BUSINESS WIRE)--Messagepoint announced today it has been named a Leader in the IDC MarketScape: Worldwide Customer Communications Management (CCM) 2022 Vendor Assessment (DOC #US48167722, June 2022). Vendor assessments involved customer interviews and a comprehensive survey to ensure vendor offerings qualified both from a capability and a strategy perspective. “Enterprise or…
Leer más...

Good Jobs for Teens are Plentiful This Summer – Here’s How Learn4Life Students are Prepared to Land Them

Business Etiquette Week highlights need for high school students to learn professional skills For Business Etiquette Week, Learn4Life highlights how professional skills courses help its students be strong candidates for summer jobs LOS ANGELES--(BUSINESS WIRE)--Math, science, history, language are all essential classes in high school, but it’s just as important…
Leer más...

ISG Launches Digital Engineering Business to Meet Booming Demand for Data- and Software-Driven Business Models

New ISG Digital Engineering advisory business will help global enterprises digitize products and create connected customer experiences STAMFORD, Conn.--(BUSINESS WIRE)--$III #Analytics--Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, today announced the launch of a digital engineering advisory business to meet booming enterprise demand in…
Leer más...

ORGOVYX® (relugolix) Now Available from Onco360 for the Treatment of Adult Patients with Advanced Prostate Cancer

LOUISVILLE, Ky.--(BUSINESS WIRE)--Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Myovant Sciences to be a specialty pharmacy partner for ORGOVYX® (relugolix), which is a gonadotropin-releasing hormone (GnRH) antagonist that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with advanced…
Leer más...